Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
Jeff M MichalskiKathryn A WinterBradley R PrestidgeMartin G SandaMahul AminWilliam S BiceHiram A GayGeoffrey S IbbottJuanita M CrookCharles N CattonAdam RabenWalter BoschDavid C BeyerSteven J FrankMichael A PapagikosSeth A RosenthalH Joseph BartholdMack RoachJennifer MoughanHoward M SandlerPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Compared with BT, COMBO did not improve FFP for prostate cancer but caused greater toxicity. BT alone can be considered as a standard treatment for men with intermediate-risk prostate cancer.